Panama

After expanding the footprint of Maxigesic IV in several European countries, Hyloris has now received regulatory approvals for the non-opioid post-operative pain treatment in South Korea and Panama. The company remains focused on increasing the global footprint of Maxigesic IV in other countries, including the US. 

The growth of e-commerce and other digital capabilities is introducing online search engines' own brands as competition for Church & Dwight's and other firms' dietary supplements and personal and household care products, says CEO Matthew Farrell.

Lilly's erectile dysfunction drug Cialis (tadalafil) has won EU approval for treating the signs and symptoms of benign prostatic hyperplasia in adult males. It is the only drug in the EU to win approval for the two indications.

Seeking to put their mark on what will be included in the $1.2 trillion in deficit reductions mandated under legislation enacted in August, House and Senate committee leaders last week gave their two cents' worth to the bipartisan 12-member "Super Congress" charged with hashing out the details – although, not much of that outpouring of advice was new.

The US Biotechnology Industry Organization (BIO) is among the organisations to have welcomed US President Barack Obama's formal submission to Congress of a long-delayed bilateral free trade pact with South Korea.

A lesson for companies in the wake of the heparin adulteration which occurred last year is that vulnerabilities can and should be monitored, Deborah Autor, director of compliance in the US FDA's drug centre, told attendees at the recent DCAT meeting in New York.

The US FDAhas opened an office in Costa Rica, its first in Latin America, in a move to ensure the quality of imported goods.

One week after US voters elected Illinois Democratic senator Barack Obama as their next president, we offer a few interesting post-election titbits on which Scrip's Washington bureau is keeping an eye (and this does not involve use of a crystal ball or a Ouija board to divine the name of the next FDA commissioner).

US FDAstaff are to be permanently posted in China, India, Europe and Latin America before the end of this calendar year.

The US FDAwill continue to receive a heightened level of funding into March 2009 under a measure passed by Congress and signed into law on September 30th.